IGF2 and gastrointestinal stromal tumor: A presumptive diagnosis of IGF-2-mediated non-diabetic hypoglycemia resulting from GIST (NICTH) was made. Given the patient's advanced age and lack of metastatic disease, a non-surgical treatment strategy was implemented. He was commenced on imatinib, a tyrosine kinase inhibitor recognized for its effectiveness in treating GISTs.